U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
MEZAGITAMAB
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD38 ANTIGEN) (HUMAN MONOCLONAL AB79 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AB79 .LAMBDA.-CHAIN, DIMER
Preferred Name English
TAK079
Code English
mezagitamab [INN]
Common Name English
Mezagitamab [WHO-DD]
Common Name English
HUMAN IGG1 ANTI CD38 MONOCLONAL ANTIBODY TAK-079
Common Name English
TAK-079
Code English
MEZAGITAMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1 (2'-PHOSPHO-ADP-RIBOSYL CYCLASE, ANTIGENE CD38))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN HUMANIZED(1-453) (HOMO SAPIENS VH (IGHV3-23*01 (89%) (IGHD)-I
Common Name English
ANTI-CD38 MONOCLONAL ANTIBODY TAK-079
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 667418
Created by admin on Wed Apr 02 00:46:56 GMT 2025 , Edited by admin on Wed Apr 02 00:46:56 GMT 2025
FDA ORPHAN DRUG 905822
Created by admin on Wed Apr 02 00:46:56 GMT 2025 , Edited by admin on Wed Apr 02 00:46:56 GMT 2025
Code System Code Type Description
USAN
HI-208
Created by admin on Wed Apr 02 00:46:56 GMT 2025 , Edited by admin on Wed Apr 02 00:46:56 GMT 2025
PRIMARY
NCI_THESAURUS
C148078
Created by admin on Wed Apr 02 00:46:56 GMT 2025 , Edited by admin on Wed Apr 02 00:46:56 GMT 2025
PRIMARY
SMS_ID
300000010802
Created by admin on Wed Apr 02 00:46:56 GMT 2025 , Edited by admin on Wed Apr 02 00:46:56 GMT 2025
PRIMARY
CAS
2227490-52-8
Created by admin on Wed Apr 02 00:46:56 GMT 2025 , Edited by admin on Wed Apr 02 00:46:56 GMT 2025
PRIMARY
FDA UNII
0XMR8L9LOL
Created by admin on Wed Apr 02 00:46:56 GMT 2025 , Edited by admin on Wed Apr 02 00:46:56 GMT 2025
PRIMARY
INN
11159
Created by admin on Wed Apr 02 00:46:56 GMT 2025 , Edited by admin on Wed Apr 02 00:46:56 GMT 2025
PRIMARY
ACTIVE MOIETY
MEZAGITAMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966